Original BioMedicals Co., Ltd. (TPEX:6483)
11.55
-0.10 (-0.86%)
Jul 22, 2025, 1:04 PM CST
Original BioMedicals Company Description
Original BioMedicals Co., Ltd., a biotechnology company, chemical entities to solve unmet medical needs in Taiwan.
It develops (A01) Radprotect, a pre-clinical product to protects against radiation exposer; (A02) CCM-Ami, which protects normal tissues from the toxic effects of chemotherapeutic agents and ionizing radiation; and ((P01)GLP-1 CCM for the treatment of type 2 diabetes.
The company was founded in 2011 and is based in Taipei, Taiwan.
Original BioMedicals Co., Ltd.
Country | Taiwan |
Founded | 2011 |
Industry | Drug Manufacturers - General |
Sector | Healthcare |
Employees | 23 |
CEO | Cliff C. Wang |
Contact Details
Address: 6F., No.415 Taipei, 74147 Taiwan | |
Phone | 886 2 2658 8599 |
Website | i-obm.com |
Stock Details
Ticker Symbol | 6483 |
Exchange | Taipei Exchange |
Stock Type | Common Stock |
Fiscal Year | January - December |
Reporting Currency | TWD |
ISIN Number | TW0006483001 |
SIC Code | 2836 |
Key Executives
Name | Position |
---|---|
Cliff C. Wang | Chief Executive Officer |
Lawrence H. T. Tang | Chief Financial Officer |
Hsiao-Pao Yen | Chief Operating Officer |